502 related articles for article (PubMed ID: 21702223)
21. Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine.
Shaikh KS; Chellampillai B; Pawar AP
Drug Dev Ind Pharm; 2010 Aug; 36(8):946-53. PubMed ID: 20196642
[TBL] [Abstract][Full Text] [Related]
22. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
Jain N; Verma A; Jain N
Drug Deliv; 2020 Dec; 27(1):888-899. PubMed ID: 32551978
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition.
Kassem AA; Abd El-Alim SH; Asfour MH
Int J Pharm; 2017 Jan; 517(1-2):256-268. PubMed ID: 27956194
[TBL] [Abstract][Full Text] [Related]
24. Formulation and ex vivo evaluation of rofecoxib gel for topical application.
Das MK; Ahmed AB
Acta Pol Pharm; 2007; 64(5):461-7. PubMed ID: 18540168
[TBL] [Abstract][Full Text] [Related]
25. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
[TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of niosomes containing ribavirin for liver targeting.
Hashim F; El-Ridy M; Nasr M; Abdallah Y
Drug Deliv; 2010 Jul; 17(5):282-7. PubMed ID: 20350052
[TBL] [Abstract][Full Text] [Related]
27. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles.
Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J
J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277
[TBL] [Abstract][Full Text] [Related]
28. Mannosylated niosomes as carrier adjuvant system for topical immunization.
Jain S; Vyas SP
J Pharm Pharmacol; 2005 Sep; 57(9):1177-84. PubMed ID: 16105238
[TBL] [Abstract][Full Text] [Related]
29. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
Hasan AA
Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
[TBL] [Abstract][Full Text] [Related]
30. Novel gel-niosomes formulations as multicomponent systems for transdermal drug delivery.
Tavano L; Gentile L; Oliviero Rossi C; Muzzalupo R
Colloids Surf B Biointerfaces; 2013 Oct; 110():281-8. PubMed ID: 23732806
[TBL] [Abstract][Full Text] [Related]
31. Effect of formulation compositions on niosomal preparations.
Chaw CS; Kim KY
Pharm Dev Technol; 2013; 18(3):667-72. PubMed ID: 22468904
[TBL] [Abstract][Full Text] [Related]
32. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
Attia IA; El-Gizawy SA; Fouda MA; Donia AM
AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
[TBL] [Abstract][Full Text] [Related]
33. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antifungal drug clotrimazole.
Ning M; Gu Z; Pan H; Yu H; Xiao K
Indian J Exp Biol; 2005 Feb; 43(2):150-7. PubMed ID: 15782815
[TBL] [Abstract][Full Text] [Related]
34. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability.
Zidan AS; Mokhtar Ibrahim M; Megrab NAE
Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295
[TBL] [Abstract][Full Text] [Related]
35. Development of Niosomal Vesicles Loaded Mometasone Furoate Gel for Transdermal Delivery and its Evaluation.
Rane BR; Chavan PY; Kate NS; Jain AS
Recent Adv Drug Deliv Formul; 2023; 17(4):300-313. PubMed ID: 37974444
[TBL] [Abstract][Full Text] [Related]
36. Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model.
Nagle A; Goyal AK; Kesarla R; Murthy RR
J Liposome Res; 2011 Jun; 21(2):134-40. PubMed ID: 20557280
[TBL] [Abstract][Full Text] [Related]
37. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.
Abdelkader H; Ismail S; Kamal A; Alany RG
Pharmazie; 2010 Nov; 65(11):811-7. PubMed ID: 21155387
[TBL] [Abstract][Full Text] [Related]
38. Preparation of curcuminoid niosomes for enhancement of skin permeation.
Rungphanichkul N; Nimmannit U; Muangsiri W; Rojsitthisak P
Pharmazie; 2011 Aug; 66(8):570-5. PubMed ID: 21901978
[TBL] [Abstract][Full Text] [Related]
39. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery.
El-Menshawe SF; Hussein AK
Pharm Dev Technol; 2013; 18(4):779-86. PubMed ID: 21913880
[TBL] [Abstract][Full Text] [Related]
40. Development and characterization of niosomal gel of fusidic acid: in-vitro and ex-vivo approaches.
Waqas MK; Sadia H; Khan MI; Omer MO; Siddique MI; Qamar S; Zaman M; Butt MH; Mustafa MW; Rasool N
Des Monomers Polym; 2022; 25(1):165-174. PubMed ID: 35711622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]